Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Chinese Patent Office
Healthtrust
Moodys
Farmers Insurance
Cantor Fitzgerald
Cerilliant
Johnson and Johnson
Fish and Richardson

Generated: January 17, 2018

DrugPatentWatch Database Preview

Ergoloid mesylates - Generic Drug Details

« Back to Dashboard

What are the generic sources for ergoloid mesylates and what is the scope of ergoloid mesylates freedom to operate?

Ergoloid mesylates
is the generic ingredient in eight branded drugs marketed by Novartis, Mutual Pharm, Sun Pharm Industries, Watson Labs, Sandoz, 3M, Bristol Myers Squibb, Kv Pharm, Lederle, Superpharm, Vangard, and Ivax Pharms, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for ergoloid mesylates. Two suppliers are listed for this compound.
Summary for ergoloid mesylates
Medical Subject Heading (MeSH) Categories for ergoloid mesylates

US Patents and Regulatory Information for ergoloid mesylates

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm ERGOLOID MESYLATES ergoloid mesylates TABLET;SUBLINGUAL 085899-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm ERGOLOID MESYLATES ergoloid mesylates TABLET;SUBLINGUAL 089233-001 Sep 23, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms HYDROGENATED ERGOT ALKALOIDS ergoloid mesylates TABLET;SUBLINGUAL 087185-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ERGOLOID MESYLATES ergoloid mesylates TABLET;SUBLINGUAL 087183-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis HYDERGINE LC ergoloid mesylates CAPSULE;ORAL 018706-001 Jan 18, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb DEAPRIL-ST ergoloid mesylates TABLET;SUBLINGUAL 085020-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
3m CIRCANOL ergoloid mesylates TABLET;SUBLINGUAL 085809-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis HYDERGINE ergoloid mesylates TABLET;ORAL 017993-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms HYDROGENATED ERGOT ALKALOIDS ergoloid mesylates TABLET;SUBLINGUAL 087186-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs GERIMAL ergoloid mesylates TABLET;ORAL 088207-001 Mar 22, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ergoloid mesylates

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis HYDERGINE LC ergoloid mesylates CAPSULE;ORAL 018706-001 Jan 18, 1983 ➤ Subscribe ➤ Subscribe
Novartis HYDERGINE ergoloid mesylates SOLUTION;ORAL 018418-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Cerilliant
Novartis
Julphar
US Army
Mallinckrodt
Dow
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot